346 related articles for article (PubMed ID: 10977437)
1. The cost of productivity losses associated with allergic rhinitis.
Crystal-Peters J; Crown WH; Goetzel RZ; Schutt DC
Am J Manag Care; 2000 Mar; 6(3):373-8. PubMed ID: 10977437
[TBL] [Abstract][Full Text] [Related]
2. Optimizing quality of care and cost effectiveness in treating allergic rhinitis in a managed care setting.
Nash DB; Sullivan SD; Mackowiak J
Am J Manag Care; 2000 Jan; 6(1 Suppl):S3-15; quiz S19-20. PubMed ID: 11009751
[TBL] [Abstract][Full Text] [Related]
3. Aeroallergens, allergic rhinitis, and sedating antihistamines: risk factors for traumatic occupational injury and economic impact.
Hanrahan LP; Paramore LC
Am J Ind Med; 2003 Oct; 44(4):438-46. PubMed ID: 14502773
[TBL] [Abstract][Full Text] [Related]
4. Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.
Sullivan PW; Follin SL; Nichol MB
Pharmacoeconomics; 2004; 22(14):929-42. PubMed ID: 15362929
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of allergic rhinitis in Korea.
Kim SY; Yoon SJ; Jo MW; Kim EJ; Kim HJ; Oh IH
Am J Rhinol Allergy; 2010; 24(5):e110-3. PubMed ID: 21244726
[TBL] [Abstract][Full Text] [Related]
6. Treatment of allergic rhinitis: effect on occupation productivity and work force costs.
Fireman P
Allergy Asthma Proc; 1997; 18(2):63-7. PubMed ID: 9134061
[TBL] [Abstract][Full Text] [Related]
7. Allergic rhinitis and the common cold--high cost to society.
Hellgren J; Cervin A; Nordling S; Bergman A; Cardell LO
Allergy; 2010 Jun; 65(6):776-83. PubMed ID: 19958315
[TBL] [Abstract][Full Text] [Related]
8. Pollen and mold exposure impairs the work performance of employees with allergic rhinitis.
Kessler RC; Almeida DM; Berglund P; Stang P
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):289-95. PubMed ID: 11686420
[TBL] [Abstract][Full Text] [Related]
9. [Allergic rhinitis--an epidemiological, economical and social problem of the XXI century].
Rutkowski R; Kosztyła-Hojna B; Rutkowska J
Pneumonol Alergol Pol; 2008; 76(5):348-52. PubMed ID: 19003765
[TBL] [Abstract][Full Text] [Related]
10. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey.
Meltzer EO; Blaiss MS; Derebery MJ; Mahr TA; Gordon BR; Sheth KK; Simmons AL; Wingertzahn MA; Boyle JM
J Allergy Clin Immunol; 2009 Sep; 124(3 Suppl):S43-70. PubMed ID: 19592081
[TBL] [Abstract][Full Text] [Related]
11. [Impact of allergic rhinitis on work productivity: a pilot study].
Kakutani C; Ogino S; Ikeda H; Enomoto T
Arerugi; 2005 Jul; 54(7):627-35. PubMed ID: 16229362
[TBL] [Abstract][Full Text] [Related]
12. Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns.
Crown WH; Olufade A; Smith MW; Nathan R
Value Health; 2003; 6(4):448-56. PubMed ID: 12859586
[TBL] [Abstract][Full Text] [Related]
13. Chronic pain and reduced work effectiveness: the hidden cost to Australian employers.
van Leeuwen MT; Blyth FM; March LM; Nicholas MK; Cousins MJ
Eur J Pain; 2006 Feb; 10(2):161-6. PubMed ID: 16310720
[TBL] [Abstract][Full Text] [Related]
14. Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines.
Stempel DA; Thomas M
Am J Manag Care; 1998 Jan; 4(1):89-96. PubMed ID: 10179909
[TBL] [Abstract][Full Text] [Related]
15. Survey on the impact of comorbid allergic rhinitis in patients with asthma.
Valovirta E; Pawankar R
BMC Pulm Med; 2006 Nov; 6 Suppl 1(Suppl 1):S3. PubMed ID: 17140421
[TBL] [Abstract][Full Text] [Related]
16. Costs associated with persistent allergic rhinitis are reduced by levocetirizine.
Bousquet J; Demarteau N; Mullol J; van den Akker-van Marle ME; Van Ganse E; Bachert C;
Allergy; 2005 Jun; 60(6):788-94. PubMed ID: 15876309
[TBL] [Abstract][Full Text] [Related]
17. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective.
Lamb CE; Ratner PH; Johnson CE; Ambegaonkar AJ; Joshi AV; Day D; Sampson N; Eng B
Curr Med Res Opin; 2006 Jun; 22(6):1203-10. PubMed ID: 16846553
[TBL] [Abstract][Full Text] [Related]
18. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
19. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis.
Sullivan PW; Follin SL; Nichol MB
Med Care; 2003 Dec; 41(12):1382-95. PubMed ID: 14668671
[TBL] [Abstract][Full Text] [Related]
20. Economic outcomes of a targeted intervention program: the costs of treating allergic rhinitis patients.
Santos R; Cifaldi M; Gregory C; Seitz P
Am J Manag Care; 1999 Apr; 5(4 Suppl):S225-34. PubMed ID: 10387543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
